Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: David Cunningham, FRCP
Woman and Man Max 99 years
David Cunningham, FRCP
Update Il y a 4 ans
A Retrospective Review of Gemcitabine, Methylprednisolone Cisplatin (GEM-P) With or Without Rituximab in Patients With Relapsed/Refractory Diffuse Large B Cell Lymphoma (DLBCL)
There has been considerable international /national interest in the GEM−P regimen for treatment of patients with relapsed/refractory lymphoma. Currently, there is no accepted standard ther...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
David Cunningham, FRCP
Update Il y a 4 ans
A Retrospective Study of Toxicity and Outcome of High Dose Chemotherapy With Autologous Stem Cell Transplant in Patients With Non-Hodgkin Lymphoma (NHL)
Patients with aggressive Non−Hodgkin−lymphoma treated at first diagnosis with chemotherapy alone or combined chemo-radiotherapy can achieve high response rates. However, patients with rela...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
David Cunningham, FRCP
Update Il y a 4 ans
A Retrospective Study of Toxicity and Outcome of High Dose Chemotherapy With Autologous Stem Cell Transplant in Patients With Hodgkin Lymphoma (HL)
The majority of patients with Hodgkin Lymphoma (HL)are cured with radiation therapy and/or combination chemotherapy. However, patients who relapse after attaining a complete remission with...
Country
None
organs
None
Specialty
None
Closed trial
More information